MARKET INTRODUCTION
Canine Atopic dermatitis is an allergic, inflammatory, chronic skin disease in dogs caused by harmless substances such as grass, mold spores, house dust mites, and other environmental allergens. The initial clinical signs of CAD associate with pruritus like (scratching, rubbing, chewing, excessive grooming, or licking). CAD is a multifactorial chronic disease that requires a multimodal treatment approach to decrease pruritus and inflammation below the threshold of clinical sign Guidelines from the International Task Force on Canine Atopic Dermatitis recommend therapeutic interventions based on identifying and managing the flare factors
MARKET DYNAMICS
Increasing incidences of atopic dermatitis in dogs fueled by air pollution and allergens are the key driver for this Canine Atopic dermatitis. According to the American College of Veterinary Dermatology (ACVD) report, around 10% to 15% of dogs suffered from this canine atopic dermatitis in 2021. The increasing number of veterinary practitioners, veterinary hospitals are one of the major factors driving the demand for this market.
MARKET SCOPE
The "Canine Atopic Dermatitis Treatment Market to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Canine Atopic Dermatitis Treatment Market with detailed market segmentation by product types and end user. The Canine Atopic Dermatitis Treatment Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Canine Atopic Dermatitis Treatment Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Canine Atopic Dermatitis Treatment Market is segmented on the basis of product, administration, and distribution channel. Based on product, the market is segmented as glucocorticoids, antihistamines, immunosuppressants, MAbs, others. Based on administration, the market is segmented as retail, E-commerce, vet pharmacies. Based on distribution channel, the market is segmented as retail, E-commerce, vet pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Canine Atopic Dermatitis Treatment Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Canine Atopic Dermatitis Treatment Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Canine Atopic Dermatitis Treatment Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the Canine Atopic Dermatitis Treatment Market in these regions.
MARKET PLAYERS
The report covers key developments in the Canine Atopic Dermatitis Treatment Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Canine Atopic Dermatitis Treatment Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Canine Atopic Dermatitis Treatment Market in the global market. Below mentioned is the list of few companies engaged in the for Canine Atopic Dermatitis Treatment Market.
The report also includes the profiles of key players in Canine Atopic Dermatitis Treatment Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Zoetis
- Virbac
- Novartis AG
- Boehringer Ingelheim International GmbH
- AB Science
- TORAY INDUSTRIES, INC.
- Elanco
- Bimeda, Inc.
- Vetoquinol S.A.
- Ceva
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Canine Atopic Dermatitis Treatment Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ XX Million |
Market Size by 2031 | US$ XX Million |
Global CAGR (2023 - 2031) | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies
1. Zoetis
2. Virbac
3. Novartis AG
4. Boehringer Ingelheim International GmbH
5. AB Science
6. TORAY INDUSTRIES, INC.
7. Elanco
8. Bimeda, Inc.
9. Vetoquinol S.A.
10. Ceva
11. Boragen Inc.,
12. Immunomic Therapeutics Inc.
13. Nexvet Biopharma
1. Zoetis
2. Virbac
3. Novartis AG
4. Boehringer Ingelheim International GmbH
5. AB Science
6. TORAY INDUSTRIES, INC.
7. Elanco
8. Bimeda, Inc.
9. Vetoquinol S.A.
10. Ceva
11. Boragen Inc.,
12. Immunomic Therapeutics Inc.
13. Nexvet Biopharma